The deadline to submit an abstract for short talk and poster presentation consideration has passed.   For any questions or issues, please email info@keystonesymposia.org.

While the field of inhibitory immune receptors has been growing steadily over the past 20 years, interest has accelerated tremendously since the application of blocking antibodies for these receptors as cancer therapies. As a general class of molecules, inhibitory immune receptors comprise hundreds of receptors across both innate and adaptive immunity. The increasing understanding of their relevance across broad facets of biology stimulates early attempts to harness them as therapeutic targets. Deeper insights into the mechanisms, characteristics and applications of these receptors continue to emerge rapidly, especially as they begin to be leveraged therapeutically outside the checkpoint receptors targeted in cancer. 

This meeting brings together scientists and physicians working on different aspects of inhibitory immune receptors biology across a range of disciplines in academia and industry. The meeting program reflects just how deeply this area penetrates into many areas of diverse biology and medicine and the interest at a global level.

Co-organizer, and Yale University School of Medicine Professor, Dr. Carla Rothlin, talks about why you should attend this meeting in the video below: